Results 221 to 230 of about 17,158 (246)
Some of the next articles are maybe not open access.
Cyclic ADP-Ribose and Vasomotor Response
2002Vascular smooth muscle (VSM) usually exists in a partially contracted state, from which it can contract further or relax in response to different physiological or pathological stimulations. This contracted state of blood vessels and their contracting and relaxing response to stimuli are often referred to as “vascular tone” and “vasomotor response ...
Pin-Lan Li +2 more
openaire +1 more source
Cyclic ADP-Ribose and Calcium Signalling
1998It is over 100 years since calcium was first implied as an intracellular regulator in heart by Ringer (1882). Since then its universal role as a regulator has become a cornerstone of cell physiology (Campbell 1983), and much progress has been made in our understanding of cellular calcium homeostasis and the way in which cellular stimuli are transduced ...
A. Galione, H. L. Wilson
openaire +1 more source
Calcium signaling by cyclic ADP-ribose and NAADP
Cell Biochemistry and Biophysics, 1998Ca2+ mobilization as a signaling mechanism has been placed on center stage with the discovery of the first Ca2+ messenger, inositol trisphosphate (IP3). This article focuses on two new Ca2+ release activators, which mobilize internal Ca2+ stores via mechanisms totally independent of IP3.
openaire +3 more sources
Cyclic ADP-Ribose: Metabolism and Calcium Mobilizing Function
1994Publisher Summary This chapter describes the discovery of cyclic adenosine diphosphate–ribose (cADPR) as a novel endogenous Ca 2+ -mobilizing agent, and the way by which it fulfills most of the criteria necessary for it to be considered a second messenger. The enzymatic pathways for the synthesis and degradation of the metabolite are also summarized.
H C, Lee, A, Galione, T F, Walseth
openaire +2 more sources
[27] Preparation of cyclic ADP-ribose antagonists and caged cyclic ADP-ribose
1997Timothy F. Walseth +6 more
openaire +1 more source
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians, 2011Timothy A Yap +2 more
exaly

